List of works - Marco Floridia

A Randomized, Double-Blind Trial on the Use of a Triple Combination Including Nevirapine, a Nonnucleoside Reverse Transcriptase HIV Inhibitor, in Antiretroviral-Naive Patients With Advanced Disease

article

A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver disease

scientific article

A randomized trial (ISS 901) of switching to didanosine versus continued zidovudine after the diagnosis of AIDS.

scientific article

A randomized trial comparing the introduction of ritonavir or indinavir in 1251 nucleoside-experienced patients with advanced HIV infection.

scientific article

AIDS dementia complex in the Italian National AIDS Registry: temporal trends (1987–93) and differential incidence according to mode of transmission of HIV-1 infection

article

Abacavir/Lamivudine and Tenofovir/Emtricitabine in Pregnant Women with Hiv: Laboratory and Clinical Outcomes in an Observational National Study.

scientific article published on 5 February 2018

Amniocentesis and chorionic villus sampling in HIV-infected pregnant women: a multicentre case series.

scientific article published on 20 June 2016

Antiretroviral therapy at conception in pregnant women with HIV in Italy: wide range of variability and frequent exposure to contraindicated drugs

article

Antiretroviral treatment in pregnancy: a six-year perspective on recent trends in prescription patterns, viral load suppression, and pregnancy outcomes

scientific article published on July 2009

Atazanavir and darunavir in pregnant women with HIV: evaluation of laboratory and clinical outcomes from an observational national study

article

Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study

scientific article published on 25 December 2013

Backbone switch to abacavir/lamivudine fixed-dose combination: implications for antiretroviral therapy optimization

scientific article published on 20 October 2015

Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.

scientific article published on 31 May 2013

Body mass index and weight gain in pregnant women with HIV: a national study in Italy

scientific article

Common occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimens

scientific article published on 12 June 2011

Concentrations of tenofovir, lamivudine and efavirenz in mothers and children enrolled under the Option B-Plus approach in Malawi

scientific article published on 17 December 2015

Cytomegalovirus (CMV) DNA load in breast milk of human immunodeficiency virus-positive women and infant CMV infection acquisition are not reduced with long-term antiretroviral therapy

scientific article published on 10 February 2017

Declining HCV seroprevalence in pregnant women with HIV.

scientific article

Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF

scientific article published in PLoS ONE

Diagnosis of HIV infection in pregnancy: data from a national cohort of pregnant women with HIV in Italy.

scientific article

Differential survival of patients with AIDS according to the 1987 and 1993 CDC case definitions

scientific article published in The Journal of the American Medical Association

Effect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAART.

scientific article published in November 2009

Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients

scientific article published on January 1995

Effectiveness of a prevention of mother-to-child HIV transmission programme in an urban hospital in Angola

scientific article

Efficacy and safety of atazanavir in patients with end-stage liver disease

scientific article

Efficacy of highly active antiretroviral therapy in HIV-infected, institutionalized orphaned children in Tanzania

scientific article

Epidemiological and Clinical Features of Pregnant Women with HIV: A 21-Year Perspective from a Highly Specialized Regional Center in Southern Italy

article

Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy

scientific article

Evolving treatment implementation among HIV-infected pregnant women and their partners: results from a national surveillance study in Italy, 2001-2015

scientific article

Factors Influencing Gestational Age-Adjusted Birthweight in a National Series of 600 Newborns from Mothers with HIV

article

Full Viral Suppression, Low-Level Viremia, and Quantifiable Plasma HIV-RNA at the End of Pregnancy in HIV-Infected Women on Antiretroviral Treatment

scientific article published on 8 April 2015

Glucose plasma levels and pregnancy outcomes in women with HIV.

scientific article published in November 2011

Good prenatal detection rate of major birth defects in HIV-infected pregnant women in Italy

article

Growth indices in breastfed infants pre and postnatally exposed to tenofovir compared with tenofovir-unexposed infants

scientific article

HBV coinfection is associated with reduced CD4 response to antiretroviral treatment in pregnancy

scientific article published on 9 January 2017

HCV-HIV coinfected pregnant women: data from a multicentre study in Italy

scientific article

HIV RNA viral load and CD4+ T-cell counts in HIV-infected pregnant women with and without treatment discontinuation in early pregnancy

article

HIV-1 DNA dynamics and variations in HIV-1 DNA protease and reverse transcriptase sequences in multidrug-resistant patients during successful raltegravir-based therapy.

scientific article published on 19 May 2016

HIV-1 viral load and resistance in genital secretions in patients taking protease-inhibitor-based second-line therapy in Africa

scientific article published on 11 October 2017

HIV-related morbidity and mortality in patients starting protease inhibitors in very advanced HIV disease (CD4 count of < 50 cells/uL): an analysis of 338 clinical events from a randomized clinical trial*

article

Health-related quality of life outcomes in HIV-infected patients starting different combination regimens in a randomized multinational trial: the INITIO-QoL substudy

scientific article published in October 2007

Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovudine

scientific article published in March 2011

Hospitalizations and Costs of Treatment for Protease Inhibitor-Based Regimens in Patients with Very Advanced HIV-Infection (CD4 < 50/mm3)

article

Impact of introducing subsidized combination treatment with artemether-lumefantrine on sales of anti-malarial monotherapies: a survey of private sector pharmacies in Huambo, Angola

scientific article published on 17 November 2016

Interindividual and intra-individual variabilities of darunavir and ritonavir plasma trough concentrations in multidrug experienced HIV patients receiving salvage regimens.

scientific article published on December 2013

Levels of bone markers in a population of infants exposed in utero and during breastfeeding to tenofovir within an Option B+ programme in Malawi.

scientific article published on 11 July 2016

Lipid profile during pregnancy in HIV-infected women.

scientific article published in July 2006

Lipodystrophy is an independent predictor of hypertriglyceridemia during pregnancy in HIV-infected women

article

Long-term follow-up of zidovudine therapy in asymptomatic HIV infection: results of a multicenter cohort study. The Italian Zidovudine Evaluation Group

article

Maternal retention and early infant HIV diagnosis in a prospective cohort study of HIV-positive women and their children in Malawi

scientific article published in 2022

Percentage and determinants of missed HIV testing in pregnancy: a survey of women delivering in the Lazio region, Italy

scientific article published on 27 November 2013

Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women

scientific article published in September 2006

Plasma HIV-1 copy number and in vitro infectivity of plasma prior to and during combination antiretroviral treatment1

article

Plasma lipid profile in pregnant women with HIV receiving nevirapine

scientific article published in March 2009

Potential anti-inflammatory effects of maraviroc in HIV-positive patients: a pilot study of inflammation, endothelial dysfunction, and coagulation markers.

scientific article published on 16 April 2014

Pregnancy and HIV infection: A european consensus on management

scientific article

Pregnancy and neonatal outcomes in women with HIV-1 exposed to integrase inhibitors, protease inhibitors and non-nucleoside reverse transcriptase inhibitors: an observational study

scientific article published on 01 January 2020

Pregnancy care in two adolescents perinatally infected with HIV

article

Pregnancy outcomes and antiretroviral treatment in a national cohort of pregnant women with HIV: overall rates and differences according to nationality

article

Pregnancy outcomes and cytomegalovirus DNAaemia in HIV-infected pregnant women with CMV.

scientific article published on 9 July 2016

Pregnancy outcomes in HIV-infected women of advanced maternal age.

scientific article published on May 2013

Pregnancy outcomes in women with advanced HIV infection in Italy

scientific article

Pregnant with HIV before age 25: data from a large national study in Italy, 2001-2016.

scientific article published on August 2017

Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues

scientific article published in August 2000

Prevalence and characteristics of symptomatic and asymptomatic tuboovarian masses in women with HIV: an ultrasonographic study

scientific article

Quality of life outcomes of combination zidovudine–didanosine–nevirapine and zidovudine–didanosine for antiretroviral-naive advanced HIV-infected patients

article

Raltegravir plasma concentrations in treatment-experienced patients receiving salvage regimens based on raltegravir with and without maraviroc coadministration

scientific article published on 6 April 2010

Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy

scientific article published on 14 July 2010

Rate and determinants of residual viremia in multidrug-experienced patients successfully treated with raltegravir-based regimens

scientific article

Rate and determinants of treatment response to different antiretroviral combination strategies in subjects presenting at HIV-1 diagnosis with advanced disease

scientific article

Rate, correlates and outcomes of repeat pregnancy in HIV-infected women.

scientific article published on 21 December 2016

Rate, predictors, and consequences of late antenatal booking in a national cohort study of pregnant women with HIV in Italy

scientific article published on May 2014

Rates of Seroprotection against Vaccine-Preventable Infectious Diseases in HIV-Exposed and -Unexposed Malawian Infants

scientific article published in 2023

Recent advances in antiretroviral therapy of HIV infection

article

Relationship between health-related quality of life measures and high HIV viral load in HIV-infected triple-class-experienced patients

scientific article

Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection

scientific article

Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (

article published in 2004

Rubella Susceptibility Profile in Pregnant Women with HIV

article

Serum Phosphate and Creatinine Levels in the First Year of Life in Infants Born to HIV-Positive Mothers Receiving Tenofovir-Based Combination Regimens During Pregnancy and Prolonged Breastfeeding in an Option B+ Program in Malawi.

scientific article

Sex differences in clinical phenotype and transitions of care among individuals dying of COVID-19 in Italy

scientific article published on 16 October 2020

Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1.

scientific article published on 13 September 2015

Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. Italian Zidovudine Evaluation Group

scientific article

The Role of COVID-19 in the Death of SARS-CoV-2-Positive Patients: A Study Based on Death Certificates

scientific article published on 27 October 2020

The effects of AZT and DDI on pre- and postimplantation mammalian embryos: an in vivo and in vitro study

scientific article published in May 1992

Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancy

scientific article

Treatment with protease inhibitors and coinfection with hepatitis C virus are independent predictors of preterm delivery in HIV-infected pregnant women.

scientific article published in March 2007

Trough concentrations of lopinavir, nelfinavir, and nevirapine with standard dosing in human immunodeficiency virus-infected pregnant women receiving 3-drug combination regimens.

scientific article published in October 2008

Tuberculosis case finding with combined rapid point of care assays (Xpert® MTB/RIF and LAM) in HIV-positive individuals starting antiretroviral treatment in Mozambique

scientific article published on 23 July 2017

Use of Specific Antiretroviral Regimens Among HIV-Infected Women in Italy at Time of Conception: 2001–2011

article

Usefulness of calcaneal quantitative ultrasound stiffness for the evaluation of bone health in HIV-1-infected subjects: comparison with dual X-ray absorptiometry

scientific article published on 31 May 2016

Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial.

scientific article published in July 2006

Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors

scientific article published in July 2012

Voluntary pregnancy termination among women with HIV in the HAART era (2002-2008): a case series from a national study

scientific article published in January 2010

[Adverse reactions to food. Notes on physiopathology, clinical features and therapy]

scientific article published on 01 September 1988

List of works by Marco Floridia

A Randomized, Double-Blind Trial on the Use of a Triple Combination Including Nevirapine, a Nonnucleoside Reverse Transcriptase HIV Inhibitor, in Antiretroviral-Naive Patients With Advanced Disease

A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver disease

A randomized trial (ISS 901) of switching to didanosine versus continued zidovudine after the diagnosis of AIDS.

A randomized trial comparing the introduction of ritonavir or indinavir in 1251 nucleoside-experienced patients with advanced HIV infection.

AIDS dementia complex in the Italian National AIDS Registry: temporal trends (1987–93) and differential incidence according to mode of transmission of HIV-1 infection

Abacavir/Lamivudine and Tenofovir/Emtricitabine in Pregnant Women with Hiv: Laboratory and Clinical Outcomes in an Observational National Study.

Amniocentesis and chorionic villus sampling in HIV-infected pregnant women: a multicentre case series.

Antiretroviral therapy at conception in pregnant women with HIV in Italy: wide range of variability and frequent exposure to contraindicated drugs

Antiretroviral treatment in pregnancy: a six-year perspective on recent trends in prescription patterns, viral load suppression, and pregnancy outcomes

Atazanavir and darunavir in pregnant women with HIV: evaluation of laboratory and clinical outcomes from an observational national study

Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study

Backbone switch to abacavir/lamivudine fixed-dose combination: implications for antiretroviral therapy optimization

Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.

Body mass index and weight gain in pregnant women with HIV: a national study in Italy

Common occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimens

Concentrations of tenofovir, lamivudine and efavirenz in mothers and children enrolled under the Option B-Plus approach in Malawi

Cytomegalovirus (CMV) DNA load in breast milk of human immunodeficiency virus-positive women and infant CMV infection acquisition are not reduced with long-term antiretroviral therapy

Declining HCV seroprevalence in pregnant women with HIV.

Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF

Diagnosis of HIV infection in pregnancy: data from a national cohort of pregnant women with HIV in Italy.

Differential survival of patients with AIDS according to the 1987 and 1993 CDC case definitions

Effect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAART.

Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients

Effectiveness of a prevention of mother-to-child HIV transmission programme in an urban hospital in Angola

Efficacy and safety of atazanavir in patients with end-stage liver disease

Efficacy of highly active antiretroviral therapy in HIV-infected, institutionalized orphaned children in Tanzania

Epidemiological and Clinical Features of Pregnant Women with HIV: A 21-Year Perspective from a Highly Specialized Regional Center in Southern Italy

Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy

Evolving treatment implementation among HIV-infected pregnant women and their partners: results from a national surveillance study in Italy, 2001-2015

Factors Influencing Gestational Age-Adjusted Birthweight in a National Series of 600 Newborns from Mothers with HIV

Full Viral Suppression, Low-Level Viremia, and Quantifiable Plasma HIV-RNA at the End of Pregnancy in HIV-Infected Women on Antiretroviral Treatment

Glucose plasma levels and pregnancy outcomes in women with HIV.

Good prenatal detection rate of major birth defects in HIV-infected pregnant women in Italy

Growth indices in breastfed infants pre and postnatally exposed to tenofovir compared with tenofovir-unexposed infants

HBV coinfection is associated with reduced CD4 response to antiretroviral treatment in pregnancy

HCV-HIV coinfected pregnant women: data from a multicentre study in Italy

HIV RNA viral load and CD4+ T-cell counts in HIV-infected pregnant women with and without treatment discontinuation in early pregnancy

HIV-1 DNA dynamics and variations in HIV-1 DNA protease and reverse transcriptase sequences in multidrug-resistant patients during successful raltegravir-based therapy.

HIV-1 viral load and resistance in genital secretions in patients taking protease-inhibitor-based second-line therapy in Africa

HIV-related morbidity and mortality in patients starting protease inhibitors in very advanced HIV disease (CD4 count of < 50 cells/uL): an analysis of 338 clinical events from a randomized clinical trial*

Health-related quality of life outcomes in HIV-infected patients starting different combination regimens in a randomized multinational trial: the INITIO-QoL substudy

Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovudine

Hospitalizations and Costs of Treatment for Protease Inhibitor-Based Regimens in Patients with Very Advanced HIV-Infection (CD4 < 50/mm3)

Impact of introducing subsidized combination treatment with artemether-lumefantrine on sales of anti-malarial monotherapies: a survey of private sector pharmacies in Huambo, Angola

Interindividual and intra-individual variabilities of darunavir and ritonavir plasma trough concentrations in multidrug experienced HIV patients receiving salvage regimens.

Levels of bone markers in a population of infants exposed in utero and during breastfeeding to tenofovir within an Option B+ programme in Malawi.

Lipid profile during pregnancy in HIV-infected women.

Lipodystrophy is an independent predictor of hypertriglyceridemia during pregnancy in HIV-infected women

Long-term follow-up of zidovudine therapy in asymptomatic HIV infection: results of a multicenter cohort study. The Italian Zidovudine Evaluation Group

Maternal retention and early infant HIV diagnosis in a prospective cohort study of HIV-positive women and their children in Malawi

Percentage and determinants of missed HIV testing in pregnancy: a survey of women delivering in the Lazio region, Italy

Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women

Plasma HIV-1 copy number and in vitro infectivity of plasma prior to and during combination antiretroviral treatment1

Plasma lipid profile in pregnant women with HIV receiving nevirapine

Potential anti-inflammatory effects of maraviroc in HIV-positive patients: a pilot study of inflammation, endothelial dysfunction, and coagulation markers.

Pregnancy and HIV infection: A european consensus on management

Pregnancy and neonatal outcomes in women with HIV-1 exposed to integrase inhibitors, protease inhibitors and non-nucleoside reverse transcriptase inhibitors: an observational study

Pregnancy care in two adolescents perinatally infected with HIV

Pregnancy outcomes and antiretroviral treatment in a national cohort of pregnant women with HIV: overall rates and differences according to nationality

Pregnancy outcomes and cytomegalovirus DNAaemia in HIV-infected pregnant women with CMV.

Pregnancy outcomes in HIV-infected women of advanced maternal age.

Pregnancy outcomes in women with advanced HIV infection in Italy

Pregnant with HIV before age 25: data from a large national study in Italy, 2001-2016.

Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues

Prevalence and characteristics of symptomatic and asymptomatic tuboovarian masses in women with HIV: an ultrasonographic study

Quality of life outcomes of combination zidovudine–didanosine–nevirapine and zidovudine–didanosine for antiretroviral-naive advanced HIV-infected patients

Raltegravir plasma concentrations in treatment-experienced patients receiving salvage regimens based on raltegravir with and without maraviroc coadministration

Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy

Rate and determinants of residual viremia in multidrug-experienced patients successfully treated with raltegravir-based regimens

Rate and determinants of treatment response to different antiretroviral combination strategies in subjects presenting at HIV-1 diagnosis with advanced disease

Rate, correlates and outcomes of repeat pregnancy in HIV-infected women.

Rate, predictors, and consequences of late antenatal booking in a national cohort study of pregnant women with HIV in Italy

Rates of Seroprotection against Vaccine-Preventable Infectious Diseases in HIV-Exposed and -Unexposed Malawian Infants

Recent advances in antiretroviral therapy of HIV infection

Relationship between health-related quality of life measures and high HIV viral load in HIV-infected triple-class-experienced patients

Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection

Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (

Rubella Susceptibility Profile in Pregnant Women with HIV

Serum Phosphate and Creatinine Levels in the First Year of Life in Infants Born to HIV-Positive Mothers Receiving Tenofovir-Based Combination Regimens During Pregnancy and Prolonged Breastfeeding in an Option B+ Program in Malawi.